Biopol Chemicals Limited (NSE:BIOPOL)

Biopol Chemicals Statistics

Total Valuation

NSE:BIOPOL has a market cap or net worth of INR 1.18 billion. The enterprise value is 1.26 billion.

Market Cap	1.18B
Enterprise Value	1.26B

Important Dates

The last earnings date was Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:BIOPOL has 10.81 million shares outstanding.

Current Share Class	10.81M
Shares Outstanding	10.81M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	67.66%
Owned by Institutions (%)	n/a
Float	2.89M

Valuation Ratios

The trailing PE ratio is 10.09.

PE Ratio	10.09
Forward PE	n/a
PS Ratio	1.45
PB Ratio	2.36
P/TBV Ratio	2.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.21, with an EV/FCF ratio of -4.67.

EV / Earnings	14.04
EV / Sales	1.55
EV / EBITDA	9.21
EV / EBIT	9.28
EV / FCF	-4.67

Financial Position

The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.17.

Current Ratio	3.73
Quick Ratio	1.92
Debt / Equity	0.17
Debt / EBITDA	0.62
Debt / FCF	-0.31
Interest Coverage	8.93

Financial Efficiency

Return on equity (ROE) is 28.29% and return on invested capital (ROIC) is 25.93%.

Return on Equity (ROE)	28.29%
Return on Assets (ROA)	16.76%
Return on Invested Capital (ROIC)	25.93%
Return on Capital Employed (ROCE)	24.67%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.61
Inventory Turnover	4.02

Taxes

In the past 12 months, NSE:BIOPOL has paid 30.84 million in taxes.

Income Tax	30.84M
Effective Tax Rate	25.58%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	101.89
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.64
Average Volume (20 Days)	90,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BIOPOL had revenue of INR 813.72 million and earned 89.74 million in profits. Earnings per share was 10.83.

Revenue	813.72M
Gross Profit	182.71M
Operating Income	135.79M
Pretax Income	120.58M
Net Income	89.74M
EBITDA	136.77M
EBIT	135.79M
Earnings Per Share (EPS)	10.83

Balance Sheet

The company has 5.18 million in cash and 84.65 million in debt, with a net cash position of -79.47 million or -7.35 per share.

Cash & Cash Equivalents	5.18M
Total Debt	84.65M
Net Cash	-79.47M
Net Cash Per Share	-7.35
Equity (Book Value)	499.21M
Book Value Per Share	53.04
Working Capital	402.87M

Cash Flow

In the last 12 months, operating cash flow was -127.66 million and capital expenditures -142.00 million, giving a free cash flow of -269.66 million.

Operating Cash Flow	-127.66M
Capital Expenditures	-142.00M
Depreciation & Amortization	983,000
Net Borrowing	7.80M
Free Cash Flow	-269.66M
FCF Per Share	-24.96

Margins

Gross margin is 22.45%, with operating and profit margins of 16.69% and 11.03%.

Gross Margin	22.45%
Operating Margin	16.69%
Pretax Margin	14.82%
Profit Margin	11.03%
EBITDA Margin	16.81%
EBIT Margin	16.69%
FCF Margin	n/a

Dividends & Yields

NSE:BIOPOL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.60%
FCF Yield	-22.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2